Solventum Corp reported $3.69B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Align Technology USD 2.73B 63.03M Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Cencora USD 55.34B 2.19B Jun/2026
Dexcom USD 3.92B 170.6M Sep/2026
Insulet USD 2.04B 192.4M Sep/2026
Solventum Corp USD 3.69B 49M Sep/2026
West Pharmaceutical Services USD 1.82B 9M Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026